TOM HEYSEK TAKES THE JOB READ ALL ABOUT IT!! In this leaderless stock market, we are reminded on a Chinese proverb that says in the land of the blind, the one-eyed man is king.
---------------------------------------------
WRITER NEEDED ASAP
Hello, Internet Promos, LLC is looking for a freelance writer specializing in Home Based Business / Money Making Opportunities / Financial & All Around Press Releases through Business Wire and other services.
FINANCIAL EXPERTISE A PLUS!
Internet Promos is an Internet company that owns an ever-growing number of Internet Properties. We own a Financial Education Center including many Financial Newsletters, Dating Services, as well as many additional Free Newsletters on diverse topics (such as: Health, Travel, Credit, Taxation, etc.) as well as an Internet Public Relations Firm specializing in the promotion of Public companies.
The problem is We Need more content!
Please e-mail resume to bkos@i-ops.com or fax to 509-693-0518.
If you feel you are right for the job, please don’t hesitate to call also. 450-227-6800 Internet Promos, LLC. Bryan Kos, President.
2/9; closes 3/10
-----------------------------------------------------------
Check out the latest Research Report on The Penny Stock Picker "VSMD" Visual Med Technology's.
i-ops.com
web.archive.org.
VisualMED Clinical Systems
by Tom Heysek
Prescription errors resulted in more than 100,000 deaths in 2000---and while this is a small number in relation to the 281 million Americans (as per the 2000 Census), there is a growing body of regulatory sentiment that there should be zero-tolerance of this particularly fatality statistic. VisualMED’s patented software contains 14 internal decision levels that make prescription errors virtually impossible.
Technological advances over the 1990’s in information accumulation, data storage, and data updating (collectively referred to as “informatics”) have altered all aspects of the manner in which businesses provide products and services in this global economy…with the notable exception of North American hospitals. Our research in the field leads us to conclude that there are three reasons for this neglect:
By the time the PC was introduced into the marketplace in 1979, efforts in the healthcare industry to automate/computerize were already well-underway, but also were largely based upon mainframe solutions. Hence, when mainframes consistently fell short on delivering desired management informatics, the bureaucratic response heretofore has been to spend more money on the problem;
Compounding this problem was the dramatic consolidation in the healthcare industry during the 1990’s; as one hospital management company took over another hospital management company, oftentimes the two operating systems were totally incompatible; and
Physicans’ input was generally less sought out by informatics professionals given the concern by both Government and the Insurance Industry to avoid potential conflicts and over-treatment of patients by physicians.
VisualMED has two Beta-site installations in operation currently, The Montreal Heart Institute and Sainte Justine Children’s Hospital. As one industry observer commented “The user of VisualMED’s systems becomes immediately aware that this is an operating system designed and developed by a physician”, which makes the VSMD family of software products user-friendly (whether that user is a physician, a nurse or the billing department), patient-protective and operationally-compliant with regulators and insurance companies.
One final healthcare industry phenomenon that makes VisualMED a timely investment opportunity is the explosion in outpatient care. The fact that there are now fewer than 1,000,000 hospital beds in the USA (versus 1.3 million in 1990) reflects the consolidation in the healthcare industry. However, over the same period, there were almost 700,000 outpatient visits last year, versus 368,000 outpatient visits in 1990. Outpatient monitoring needs and delivery of healthcare services differ from inpatient care but in addition, a hospital’s operating system must track/follow that patient throughout the healthcare facility’s various functionalities.
The VisualMED patented (pending) suite of software products is sufficiently dynamic to track patient care from check-in, to delivery of “service”, to check-out with greater accuracy, more efficient delivery of service and at lesser operating cost.
VisualMED is currently being Beta-tested at two healthcare facilities: The Montreal Heart Institute; and St. Justine’s Children’s hospital. In the pursuit of the most up to date information for our readers we took the initiative to call the persons in charge of the Beta-testing of VSMD’s software installation. Mr. Daniel Guindon has been Project Manager at St. Justine’s since last October, when VisualMED’s software installation began. Prior to being Project Manager for St. Justine’s, Mr. Guindon was Chief Emergency Room Nurse since 1989. Dr. Richard Marchand is Director of Microbiology at The Heart Institute.
We share these recurring comments with you:
The VisualMED technology works, and in the process of selecting VSMD as the software vendor, operating performance was not only superior but less costly in relation to all available alternatives.
Paperwork is virtually eliminated.
Functionalities, therapies and work stations are all color coded, and along with the imbedded internal controls, mistakes are highly improbable.
We went one step further and talked with several lower level personnel. While these individuals were not as conversant with the technology, we asked their opinion of the two best features of this software. The answers:
(i)Not having to read physicians’ hand-writing; and
(ii)The absence of routine, mundane forms.
For more information on VSMD and to be kept up to date on the latest news please click here and subscribe for more FREE Information from The Penny Stock Picker! And check out our follow-up report, which will include a forecast of operating results.
What about the Competition?: VSMD is not the only company in this commercial space (informatics services to hospitals). Cerner (CERN) and Eclipsys (ECLP) together derive over $600 million in sales, however, their systems are mainframe-enabled whereas VSMD's patented technology is PC-enabled and is, by virtue of this fundamental difference, unique.
As confirmation that VSMD's technology is where the market is, not only are sales actually declining at CERN and ECLP, but both companies are losing money."
CERN does report income of $105 million, however, investigating its footnotes, we discovered this included a gain of $188 million on an exchange of stock. Eliminating that non-operating gain, CERN actually lost almost $80 million. Moreover, the short interest in CERN is a whopping 12% of shares outstanding.
In this leaderless stock market, we are reminded on a Chinese proverb that says in the land of the blind, the one-eyed man is king. VisualMED should be part of your investment vision--- if you are an experienced investor you might want to accumulate a $25,000 position over the next five trading days (15,000 to 20,000 shares), with an Exit Strategy north of $4 per share. If you are a new investor you may want to begin with a smaller investment of $500.00 or more depending on your budget. Please read our disclaimer.
In conclusion, and to recap, check out the above referenced web sites, make a financial commitment to purchase anywhere from 100 – 1000 or more (for the newer investor) and 15,000 to 20,000 shares over five days with your online broker (if you are a more experienced investor), and give your position a 90 day period to work itself in your favor. In a world where nothing is unique for very long, VisualMED sure comes close.
MESSAGE TO ALL SUBSCRIBERS & NEW SUBSCRIBERS: I will be updating the subscribers of this report with a continual flow of information about VSMD including a FAQ (Frequently Asked Questions) with the management of VSMD over the next week to two weeks. Please subscribe in order to receive continual updates on VisualMED Clinical Systems.
Tom Heysek
Research Analyst
EMAILBAG FOR TOM HEYSEK!
Contact me if you would like my FREE REPORT "Exit Wounds" which shows how Individual investors are witnessing a once-in-a-generation market phenomenon---"The relentless readjustment of corporate valuations amidst a shift toward more fundamental barometers of worth".
Bonus Offer: All subscribers will also receive Tom Heysek’s FREE Report on “THE TEN COMMANDMENTS FOR THE INDIVIDUAL INVESTOR”. Subscribe Now!
If you have any questions for me concerning this report on VSMD please complete the contact form on this web site.
COMING NEXT WEEK
***********
Join us for a Question and Answer interview with Dr. Gelston President of VisualMED Clinical Systems.
If you haven't subscribed to The Penny Stock Picker News yet, please click here!
--------------------------------------------------------------------------------
Please click here to read our DISCLAIMER |
